Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SABSW SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM)

Watchlist
0.060
-0.007-10.45%
Close  02/03 16:00 ET
High
0.060
Open
0.060
Turnover
60.00
Low
0.060
Pre Close
0.067
Volume
986.00
Market Cap
0
P/E(TTM)
0.00
52wk High
1.190
Shares
0
P/E(Static)
0.00
52wk Low
0.028
Float Cap
0
Bid/Ask %
-81.82%
Historical High
3.320
Shs Float
0
Volume Ratio
0.26
Historical Low
0.028
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.060
Lot Size
1
Float Cap
0
Bid/Ask %
-81.82%
Historical High
3.320
Shs Float
0
Volume Ratio
0.26
Historical Low
0.028
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.060
Lot Size
1
Price Forecast

News

Comment

Company Overview More
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company. It is engaged in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. SAB Biotherapeutics was founded by Eddie J. Sullivan and Christine E. Hamilton and is headquartered in Sioux Falls, SD.
CEO: Dr. Eddie J. Sullivan, PhD
Market: NASDAQ
Listing Date: 02/09/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist